GMJ Briefs
Clinical Trial Data Reveals Survodutide’s Superior Weight Loss Efficacy: 17.5% Reduction at Highest Dose
17.5% mean weight loss achieved with highest survodutide dose, with over 60% of participants reaching clinically significant 15% reduction threshold.
Three Critical Facts About Mental Health as the World’s Leading Disability
Half of mental health disorders begin before age 14, highlighting the importance of early intervention and prevention.
What Practitioners Need to Know About the New Grid-Based Prosthetic Assessment System
Grid-based prosthetic assessment achieves 88% reliability and requires only basic photography, enabling objective wear monitoring in resource-constrained clinics.
UK launches meningitis B vaccine programme for students after deadly outbreaks
The UK is launching a meningitis B vaccination programme this summer, targeting students aged 17–24 following a deadly outbreak in…
Ebola outbreak in DRC vastly undercounted, Africa CDC warns as insecurity hampers response
The Africa CDC warns that confirmed Ebola cases in DRC's North Kivu province represent only a fraction of actual infections,…
COVID-19 Boosters May Protect Against Future Animal Coronaviruses, Cambridge Study Shows
Researchers at the University of Cambridge have demonstrated that COVID-19 vaccine boosters may confer protective immunity against some future coronaviruses…
Ebola Outbreak in DR Congo Outpaces Response Efforts, WHO Warns
The Ebola outbreak in the Democratic Republic of the Congo spreads faster than response interventions can contain it, despite expanded…
BMJ Framework Transforms How Healthcare Teams Address Unprofessional Patient Comments
New BMJ guidance offers healthcare institutions a structured framework for addressing colleague derogatory comments through constructive dialogue and intent assessment…